Fingerprint
Dive into the research topics of 'Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Real-world efficacy of osimertinib in previously EGFR-TKI treated NSCLC patients without identification of T790M mutation
Yung Hung Luo, Han Liu, Jason A. Wampfler, Henry D. Tazelaar, Yalun Li, Tobias Peikert, Dan Liu, Konstantinos Leventakos, Yuh Min Chen, Yanan Yang, Shih Hwa Chiou, Ping Yang
Research output: Contribution to journal › Article › peer-review